Yestar Healthcare Holdings Issues Profit Warning for FY2025

Key Points from the Announcement

• Significant Financial Turnaround: Yestar Healthcare Holdings Company Limited (“the Company”) has announced a profit warning, expecting a consolidated net loss of not less than RMB65 million for the year ended 31 December 2025 (FY2025). This is a sharp reversal from the previous year’s consolidated net profit of approximately RMB903.5 million for FY2024.
• Absence of One-Time Gain: The profit recorded in FY2024 was largely due to a one-off gain of approximately RMB1,083.4 million stemming from the redemption of the Company’s senior notes due in 2026 at a discount. This gain did not recur in FY2025, significantly impacting the Group’s profitability.
• Impairment Losses: The Group also recognized impairment losses on non-financial assets in FY2025, further contributing to the net loss.
• Preliminary Figures: The figures presented are based on unaudited management accounts and may be subject to adjustments following further internal review. The audited financial results for FY2025 are expected to be published on 27 March 2026.

Important Information for Shareholders and Investors

• Sharp Reversal in Financial Performance: The anticipated loss for FY2025, compared to the substantial profit in FY2024, is a major development that could affect investor sentiment and share price. The absence of extraordinary gains and recognition of impairment losses indicate underlying challenges in the Group’s core business operations.
• Potential Share Price Impact: Such a dramatic turnaround in the Company’s financial results is likely to be price-sensitive and may lead to volatility in the Company’s share price. Shareholders and potential investors should exercise caution when dealing in the shares.
• Ongoing Review: As the results are preliminary and unaudited, there may be further adjustments before the official announcement. Investors should monitor for the release of the audited results for more definitive information.
• Board and Management: The announcement was authorized by CEO and Executive Director Wang Chunlai. The Board consists of both executive and independent non-executive directors, reflecting ongoing corporate governance.

Timeline and Next Steps

• The Company’s audited financial results for FY2025 are expected to be released on 27 March 2026.
• Investors should stay alert for further updates and announcements from the Company that may provide additional clarity or details regarding the financial situation.

Conclusion

Yestar Healthcare Holdings’ announcement of a substantial expected net loss for FY2025 marks a significant change in its financial trajectory. The loss stems primarily from the absence of last year’s extraordinary gain and new impairment losses. Shareholders and potential investors should be aware of the potential for share price volatility and are advised to exercise caution until the audited results are released.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should consider their own circumstances and consult professional advisors before making any investment decisions based on this information.

View YESTAR HEALTH Historical chart here